 DarioHealth Corp NASDAQ: DRIO reported second-quarter FY21 revenue growth of 194 year-on-year to 5.26 million, beating the analyst consensus of 5.11 million. The non-GAAP billings rose 186 YY to 5.13 million from higher sales and the consolidation of Upright revenues. 